Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

Failures in Alzheimer's disease (AD) drug trials highlight the need to further explore disease mechanisms and alterations of biomarkers during the development of AD. Using cross‐sectional data from 377 participants in the BioFINDER study, we examined seven cerebrospinal fluid (CSF) and six plas...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmqvist, Sebastian, Insel, Philip S, Stomrud, Erik, Janelidze, Shorena, Zetterberg, Henrik, Brix, Britta, Eichenlaub, Udo, Dage, Jeffrey L, Chai, Xiyun, Blennow, Kaj, Mattsson, Niklas, Hansson, Oskar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895602/
https://www.ncbi.nlm.nih.gov/pubmed/31709776
http://dx.doi.org/10.15252/emmm.201911170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895602/
https://www.ncbi.nlm.nih.gov/pubmed/31709776
http://dx.doi.org/10.15252/emmm.201911170

Ejemplares similares